Common nasal swab tested to fight Drug-Resistant superbug

NCT ID NCT06282510

Summary

This study is testing whether applying a common over-the-counter antiseptic (povidone iodine) inside the nose can reduce the amount of a dangerous, drug-resistant fungus called Candida auris that people carry. The trial involves 120 patients in Chicago-area hospitals who are already colonized with the fungus. Researchers will compare those who use the nasal antiseptic for five days to those who receive no treatment, checking if it reduces the fungus on their bodies and in their rooms.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLONIZATION, ASYMPTOMATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • RML Specialty Hospital

    RECRUITING

    Chicago, Illinois, 60624, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • RML Specialty Hospital

    RECRUITING

    Hinsdale, Illinois, 60521, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rush University Medical Center

    RECRUITING

    Chicago, Illinois, 60612, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.